Rules – Documentation

DODD FRANK ACT

In connection with any transactions in OTC derivatives and pursuant to U.S. Commodity Futures Trading Commission (CFTC) Regulation 23.431, the Bank is providing you with disclosures regarding the risks of investing in swaps, the material economic terms of frequently traded swaps, and the material incentives and conflicts of interest we may have with respect to swap transactions. In the Dodd-Frank Act section, disclosures generally applicable to all swaps are provided in the General Disclosures area. Product specific disclosures, including the material economic terms (METs), are organized into different product classes traded by the bank.

EMIR

The European Market Infrastructure Regulation (EMIR) went into effect in Italy and in every European country on 16 August 2012. The objectives of the regulation are to be pursued through specific obligations applicable to clearing members which operates with central counterparties.

MiFID

The Markets in Financial Instruments Directive (MiFID II) came into force in all European Union member states on 3rd January 2018. One of its main aims is to create a competitive and harmonised financial environment for regulated markets and investment firms, as well as to strengthen investors' protection and the efficiency and integrity of the financial markets themselves. The scope of the previous European Directive (MiFID I) is also extended with reference to disclosure and transparency obligations before and after the sale of financial instruments and the reporting and alignment of financial transactions. Hereby are attached more information with reference to:

• Financial Profile, based on the MiFID Questionnaire:

• Contract Governing the Provision of Investment Services, which regulates investment services, accounting positions and the custody and administration of securities and financial instruments:

• Terms of Business, which sets out the principles governing the negotiation service on own account in OTC derivatives of Clients without the provision of investment advisory service:

• Document explaining the criteria for MiFID Client Classification, the procedure for requesting a change in the classification attributed by the Bank and the main implications arising from the classification assigned:

• Regulatory Information Document of the MIFID II Directive, summarizing the fundamental information concerning: the Bank, the financial instruments, the investment services provided, the strategy for transmission and execution of orders, conflicts of interest, incentives and recording of telephone conversations and electronic communications:

Further documentation for information purposes pursuant to the MiFID II Directive is available in the "Reserved Area" section of the website https://www.bancaimi.com/en/bancaimi.

CSDR

According to Article 38 (6) of Regulation (EU) No 909/2014 on improving securities settlement in the European Union and on central securities depositories, CSDs Direct Participants shall disclose the levels of protection and the costs associated with the different levels of account segregation.

PROSPECTUSES – ISSUANCES - PRODUCT DISTRIBUTION

WARNING

By accessing information and documentation relating to the financial instruments included in this website ("Securities") you declare that you are not a US Person (as defined below). Furthermore, you also note the following. The offer of the Securities is made to the general public in a specific jurisdiction and any offer, solicitation of an offer, distribution of marketing material relating to the Securities will not be made in the United States of America, Canada, Australia, Japan or any other country where such acts are forbidden without specific exemptions or authorizations from the relevant competent authorities (the "Other Countries"). No Offer may be made in the United States of America, or to any citizen, resident, taxable persons in the United States of America ("U.S. Person" or "United States Person" within the meaning of U.S. Securities Laws or other relevant local regulations, a US Person) and no distribution of any offering documents may be made in the United States of America. The Securities have not been and will not be registered nor under the United States Securities Act of 1993, as from time to time amended, neither under any financial rules applicable in the United States of America. Neither the Securities and Exchange Commission ("SEC") nor any other supervisory authorities in the United States of America has approved or has not approved the issuance and/or the Offer of the Securities or has taken any position as to the accuracy or inaccuracy of the Prospectus and/or the Final Terms/Condizioni Definitive of the Securities. According to the provisions of the United States Commodity Exchange Act, trading in the Securities has not been approved by the United States Commodity Futures Trading Commission ("CFTC"). The Securities have not been and will not be registered under the existing securities rules applicable in Canada, Japan, Australia or in the Other Countries, and therefore they may not be, directly or indirectly, offered, sold or otherwise delivered in Canada, Japan, Australia and in the Other Countries or to any citizen, resident, taxable persons in Canada, Japan, Australia and the Other Countries and the documentation relating to the Offer may not be distributed in Canada, Japan, Australia and the Other Countries. In any event no person, being US Person or resident in Canada, Japan, Australia and the Other Countries under the US Securities Laws or under any other local applicable rule, may join the Offer. You also declare that you have read and fully understood and that you agree to comply with the above selling restrictions and undertake not to transmit any document relating to the Offer of the Securities in the United States of America, Canada, Australia, Japan or in the Other Countries. WARNING: the above declarations constitute self-certification pursuant to Decree by the President of the Republic No. 445 of 28 December 2000. False declarations are punishable by law.

BASE PROSPECTUSES

PRODUCT DISTRIBUTION

List of products for which Intesa Sanpaolo is the issuer. Hereafter you find the detailed documentation of the product offered.

• Intesa Sanpaolo S.P.A. MAX LONG CAP CERTIFICATES on S&P 500® Index due 30.07.2027 – ISIN: XS2195347013

• Intesa Sanpaolo S.P.A. MAX LONG CAP CERTIFICATES on STOXX® EUROPE 600 HEALTH CARE (EUR – PRICE) Index due 30.07.2027 – ISIN: XS2195346718

• Intesa Sanpaolo S.P.A. STANDARD LONG DIGITAL CERTIFICATES on LBMA Gold Price Index due 30.07.2027 – ISIN: XS2195246090

• Intesa Sanpaolo S.P.A. STANDARD LONG DIGITAL CERTIFICATES WITH MEMORY EFFECT on EURO STOXX® Select Dividend 30 Index due 30.07.2027 – ISIN: XS2195237008

• Intesa Sanpaolo S.P.A. MAX LONG CERTIFICATES on STOXX® GLOBAL SELECT DIVIDEND 100 (EUR – PRICE) Index due 05.08.2027 – ISIN: XS2197360618

• Intesa Sanpaolo S.P.A. STANDARD LONG BARRIER PLUS CERTIFICATES on EURO STOXX 50® Index due 12.08.2024 – ISIN: XS2199658936

• Intesa Sanpaolo S.P.A. MAX LONG CAP CERTIFICATES on STOXX® GLOBAL SELECT DIVIDEND 100 (EUR - PRICE) Index due 11.08.2025 – ISIN: XS2199677217

For all the other issuances please refer to the web page group.intesasanpaolo.com/en/investor-relations